GPRC6A and prostate carcinoma: In recent years TRPM8 (transient receptor potential cation channel subfamily M member 8) and GPRC6A (G protein-coupled receptor class C group 6 member A) proteins were demonstrated to mediate the action of androgens in prostate cancer cells [48,49,50].